168
Views
56
CrossRef citations to date
0
Altmetric
Original

Ceruloplasmin and myeloperoxidase in complex affect the enzymatic properties of each other

, , , , , , , & show all
Pages 989-998 | Received 21 Aug 2008, Published online: 07 Jul 2009
 

Abstract

Ceruloplasmin (CP), the multicopper oxidase of plasma, interacts with myeloperoxidase (MPO), an enzyme of leukocytes, and inhibits its peroxidase and chlorinating activity. Studies on the enzymatic properties shows that CP behaves as a competitive inhibitor impeding the binding of aromatic substrates to the active centre of MPO. The contact between CP and MPO probably entails conformational changes close to the p-phenylenediamine binding site in CP, which explains the observed activation by MPO of the substrate's oxidation. CP subjected to partial proteolysis was virtually unable to inhibit activity of MPO. The possible protein–protein interface is comprised of the area near active site of MPO and the loop linking domains 5 and 6 in CP. One of the outcomes of this study is the finding of a new link between antioxidant properties of CP and its susceptibility to proteolysis.

Abbreviations
ABTS=

2,2′-azino-di(3-ethylbenzthiazolinesulphonic acid) disodium salt

CP=

ceruloplasmin

LF=

lactoferrin

MPO=

myeloperoxidase

p-PD=

p-phenylenediamine.

Abbreviations
ABTS=

2,2′-azino-di(3-ethylbenzthiazolinesulphonic acid) disodium salt

CP=

ceruloplasmin

LF=

lactoferrin

MPO=

myeloperoxidase

p-PD=

p-phenylenediamine.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.